GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » FCF Yield %

Rhythm Biosciences (ASX:RHY) FCF Yield % : -48.58 (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Rhythm Biosciences's Trailing 12-Month Free Cash Flow is A$-8.33 Mil, and Market Cap is A$17.15 Mil. Therefore, Rhythm Biosciences's FCF Yield % for today is -48.58%.

The historical rank and industry rank for Rhythm Biosciences's FCF Yield % or its related term are showing as below:

ASX:RHY' s FCF Yield % Range Over the Past 10 Years
Min: -50.03   Med: 0   Max: 0
Current: -48.58


ASX:RHY's FCF Yield % is ranked worse than
84.48% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.815 vs ASX:RHY: -48.58

Rhythm Biosciences's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Rhythm Biosciences FCF Yield % Historical Data

The historical data trend for Rhythm Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences FCF Yield % Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Yield %
Get a 7-Day Free Trial -16.83 -35.04 -3.06 -2.65 -7.83

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.33 -3.55 -1.73 -11.54 -20.98

Competitive Comparison of Rhythm Biosciences's FCF Yield %

For the Diagnostics & Research subindustry, Rhythm Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhythm Biosciences's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's FCF Yield % falls into.



Rhythm Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Rhythm Biosciences's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-7.057 / 90.114653796
=-7.83%

Rhythm Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.131 * 2 / 29.854014127
=-20.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhythm Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Rhythm Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhythm Biosciences (ASX:RHY) Business Description

Traded in Other Exchanges
Address
30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines